TW201233341A - Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid - Google Patents
Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid Download PDFInfo
- Publication number
- TW201233341A TW201233341A TW100148124A TW100148124A TW201233341A TW 201233341 A TW201233341 A TW 201233341A TW 100148124 A TW100148124 A TW 100148124A TW 100148124 A TW100148124 A TW 100148124A TW 201233341 A TW201233341 A TW 201233341A
- Authority
- TW
- Taiwan
- Prior art keywords
- weight
- nutritional
- calcium
- protein
- nutrient solution
- Prior art date
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
201233341 六、發明說明: 【發明所屬之技術領域】 本發明係關於包含蛋白質、β_羥基_β甲基丁酸鈣(HMB 約)及共軛亞油酸(CLA)之固體及液體營養產品。 【先前技術】 包含依目標選擇之營養成份之含蛋白質營養液及粉末已 為業内所熟知且廣泛利用,其争之一些可提供專用營養來 源,而其他可提供補充性來源。該等含蛋白質營養品包括 可用水或其他水性液體重構之粉末以及即飲營養液,例如 基於乳或蛋白質之乳液或非乳化液體。通常使用含蛋白質 營養品來改良或維持運動員以及具有與骨骼肌萎縮有關之 疾病或病狀風險或患有該疾病或病狀之個體的肌肉健康。 已知用於影響肌肉健康之其他營養素包括β_羥基_p甲基 丁酸鹽(ΗΜΒ)。ΗΜΒ係用於多種營養產品及補充劑中之天 然存在之胺基酸代謝物。ΗΜΒ幫助構建或維持所選個體之 健康肌肉質量及力量。ΗΜΒ鈣係調配成口服營養產品時 ΗΜΒ之常用形式,該等產品可包括錠劑、膠囊、可重構粉 末、營養液及乳液。 已知用於景> 響肌肉健康之再一營養素係共輛亞油酸 (CLA)。CLA通常係指亞油酸之至少28種同分異構體之群 中之任一或多者。已顯示CLA減少體脂肪並增加肌肉質 量’且亦已顯示具有抗癌及抗氧化特性。由於CLA具有明 顯的苦味且在口服時引起咽喉燒灼感,故最通常將其納入 膠囊及丸劑中以使該等效應最小化。 161134.doc 201233341 因此,將期望向個體投與蛋白質、CLA及HMB以影響肌 肉健康,此尤其由於該三種營養素藉以提供該等效應之機 制或途徑不相同。亦甚至將期望自單一營養產品(尤其營 養液)投與所有三種成份,儘管迄今為止由於每一者之產 研發需要此尚為一項挑戰。在營養液中,cLA具有苦味 且引起咽喉燒灼感,而來自大多數HMB來源(或其他鈣來 源)之可溶性鈣負載可導致所添加的許多類型蛋白質沉 殿’使得產品潛在地不穩定。 因此’本發明係關於包含相對高濃度之HMB鈣、CLA及 蛋白質之營養液及粉末’其中所得營養產品在儲架壽命内 物理上穩定且提供有利的美學及感官品質。 【發明内容】 一個實施例係關於包含約〇 〇1重量%至約1〇重量%之 HMB妈、約〇·〇ι重量%至約1〇重量%之共軛亞油酸、約1 〇 重量%至約30重量%之蛋白質及約50重量%至約98重量%之 水的營養液。 另一實施例係關於包含約〇.〇 1重量%至約1 〇重量%之 HMB鈣、約〇_〇1重量%至約1〇重量%之共軛亞油酸及約i 〇 重量%至約40重量%之蛋白質的營養粉末。 另一實施例係關於包含HMB鈣、共軛亞油酸、蛋白質、 脂肪及碳水化合物之營養產品。 另一實施例係關於改良包含HMB鈣之營養產品之物理穩 定性的方法。該方法包含向營養產品中引入共軛亞油酸, 其中共軛亞油酸與HMB鈣之重量比係約1.8:1至約2.3:1。 161134.doc 201233341 已發現,向營養產品(例如營養液及固體)中添加cla會 導致產品具有苦味或白奎味且在食用後具有明顯的咽喉燒 灼效應,甚至在非常低漢度下亦如此。亦已發現,包人 HMB鈣與蛋白質之組合之許多營養液(例如營養乳液)在= 理上不穩定,通常導致在乳液容器底部聚集過多蛋白質或 其他沈積物,由此潛在降低營養素之可用性以及縮短產品 之有效儲架壽命。 現已令人驚奇地發現,可藉由用HMB鈣、CLa及蛋白質 之組合調配營養產品來最小化或消除該等不穩定性及氣味 問題。本文所述之營養產品包含HMB鈣、CLA及蛋白質之 具體組合,其不僅為個體提供關於肌肉力量、健康及功能 方面之益處’而且在每-所選產品形式中均提供改良之物 理穩定性、感官及/或美學益處。 【實施方式】 本發月中所述之營養產品包含飼、及蛋白質。 :等營養產品具有商業上可接受之味道特性,且長期穩 甚至在呈液體形式時亦如此。下文詳細描述營養產品 之忒等及其他特徵 '以及許多可選變化及添加中的一些。 π除非另有说明,否則本文所用之術語「HMB鈣」係指卜 、β甲基丁酸鹽(亦稱為卜羥基p甲基丁酸、卜羥基_3_ :丁 S欠' β•羥基異戊酸或ΗΜΒ)之鈣鹽,其最通常以單 ^ °㈣式存在。除非另有說明’否則本文用以描述ΗΜΒ 妈特徵之所右畲旦 另里里、百分比及濃度皆係基於ΗΜΒ鈣單水人 物之重量。 。 161134.doc 201233341 除非另有說明,否則本文所用之術語「脂肪」及「油」 可互換使用,且係指來源於植物或動物或自植物或動物加 工之脂質物質。該等術語亦包括合成脂質物質,只要該等 合成物質適於口服投與人類即可。 除非另有說明,否則本文所用之術語「儲架穩定」係指 營養液經包裝且㈣下儲存至少3個月(包括約6 個月至約24则,且亦包括約12個月至約18個月)之後保 持商業上穩定。 營養產品」係指 且適於由人類口 除非另有說明,否則本文所用之術語「 包含蛋白質及一或多種脂肪及碳水化合物 服食用之液體及粉末。 除非另有說明,否則本文所用之術語「營養液」係指呈 =液㈣式之營養產品以及藉由在使用前對本文所述之 呂養粉末實施重構而製得之營養液。 比、份數及比 否則與所列出 質含量,且因 除非另有說明,否則本文所用之所有百分 率皆以總組合物之重量計。除非另有說明, 之成份相關之所有該等重量皆係基於活性物 不匕括市售物質中可包括之溶劑或副產物 除非另有說明或所提及 形,否則所有提及本發明 括相應之複數特徵或限制 内容之上下文明確暗示相反之情 之單數特徵或限制之内容皆應包 ’反之亦然。 及組合之上下文明確暗示相反之情 方法或加工步驟之所有組合均可以任 除非另有說明或提 形,否則本文所使用 一順序實施。 161134.doc 201233341 本發明之營養產品之各種實施例亦可管哲l 負上不含本文所 述之任-可選或所選基本成份或特徵,前提條件係其餘營 養產品仍含有如本文所述之所有所需成份或特徵。在此: 下文中,且除非另有說明,否則術語「實質上不人 所選營養產品含有少於功能量之所提及可選成份,丄^ = 選或所選基本成份之重量計,通常少於約1 J A.0/o,包括少於 約0.5%、包括少於約〇.〗%、且亦包括〇%。 §亥等營養產品可包含如本文所述之產品之基本要素以及 本文所述或可用於營養產品應用中之任—額外或可選要 素、由其組成或基本上由其組成。 產品形式 本發明之營養產品包括液體及粉末兩種形式。液體可包 括溶液、懸浮液及乳液。粉末可包括可在使用前用水或其 他水性液體稀釋以形成營養液之任何可流動或可岛取之微 粒固體或鏡劑。 該等營養產品可用足夠種類及量之營養素加以調配,以 提供專用、主要或補充性營養來源,或提供用於患有具體 疾病或病狀或具有目標營養益處之個體之專門營養產品。 營養粉末 該等營養粉末(包括壓製或固體營養粉末,包括錠劑形 式)可由預期使用者用適宜水性液體(通常為水或其他水性 液體)加以重構,以形成用於即刻口服或腸内使用之營養 液。在此上下文中,「即刻」使用通常意指在重構後之約 48小時内、更通常在約24小時内、最通常在重構後立刻或 161134.doc 201233341 在20分鐘内使用。 該等營養粉末可包括噴霧乾燥 粉末、幹式混合粉末、聚201233341 VI. Description of the Invention: TECHNICAL FIELD OF THE INVENTION The present invention relates to solid and liquid nutritional products comprising protein, beta-hydroxy-beta methylbutyrate (HMB about) and conjugated linoleic acid (CLA). [Prior Art] Protein-containing nutrient solutions and powders containing nutritionally selected ingredients are well known and widely used in the industry, some of which provide a dedicated source of nutrition, while others provide a complementary source. Such protein-containing nutrients include powders that can be reconstituted with water or other aqueous liquids, as well as ready-to-drink nutrient solutions, such as milk or protein based emulsions or non-emulsified liquids. Protein-containing supplements are typically used to improve or maintain the muscle health of an athlete and an individual at risk of or suffering from a disease or condition associated with skeletal muscle atrophy. Other nutrients known to affect muscle health include beta-hydroxy-p methylbutyrate (ΗΜΒ). Lanthanide is a naturally occurring amino acid metabolite present in a variety of nutritional products and supplements. ΗΜΒ Help build or maintain healthy muscle mass and strength in selected individuals. When calcium is formulated into oral nutritional products, it is commonly used in the form of tablets, capsules, reconstitutable powders, nutrient solutions and lotions. A further nutrient known to be used for bokeh> muscle health is a total of linoleic acid (CLA). CLA generally refers to any one or more of the group of at least 28 isomers of linoleic acid. CLA has been shown to reduce body fat and increase muscle mass' and has also been shown to have anti-cancer and antioxidant properties. Since CLA has a marked bitter taste and causes a burning sensation in the mouth when taken orally, it is most commonly incorporated into capsules and pills to minimize these effects. 161134.doc 201233341 Therefore, it would be desirable to administer proteins, CLA, and HMB to individuals to affect muscle health, particularly because of the different mechanisms or pathways by which the three nutrients provide such effects. It would even be desirable to administer all three ingredients from a single nutritional product (especially a nutrient solution), although this has been a challenge to date due to the need for research and development in each of them. In nutrient solutions, cLA has a bitter taste and causes a burning sensation in the throat, while soluble calcium loading from most HMB sources (or other sources of calcium) can cause many types of protein sinks to be added, making the product potentially unstable. Thus, the present invention relates to nutrient solutions and powders comprising relatively high concentrations of HMB calcium, CLA and protein. The resulting nutritional product is physically stable over shelf life and provides advantageous aesthetic and sensory qualities. SUMMARY OF THE INVENTION One embodiment relates to a conjugated linoleic acid containing from about 1% by weight to about 1% by weight of HMB, about 5% by weight to about 1% by weight, about 1 〇 by weight. % to about 30% by weight of protein and from about 50% to about 98% by weight of nutrient solution of water. Another embodiment relates to a conjugated linoleic acid comprising from about 1% by weight to about 1% by weight of HMB calcium, from about 〇_〇1% by weight to about 1% by weight, and about i 〇% by weight to A nutritional powder of about 40% by weight protein. Another embodiment relates to a nutritional product comprising calcium HMB, conjugated linoleic acid, protein, fat, and carbohydrates. Another embodiment relates to a method of improving the physical stability of a nutritional product comprising HMB calcium. The method comprises introducing a conjugated linoleic acid to the nutritional product, wherein the weight ratio of conjugated linoleic acid to HMB calcium is from about 1.8:1 to about 2.3:1. 161134.doc 201233341 It has been found that the addition of cla to nutritional products (such as nutrient solutions and solids) results in a bitter or white scent of the product and a pronounced throat burning effect after consumption, even at very low levels. It has also been found that many nutrient solutions (e.g., nutritional emulsions) that combine human HMB calcium with protein are not statistically stable, often resulting in the accumulation of excess protein or other deposits at the bottom of the emulsion container, thereby potentially reducing the availability of nutrients and Shorten the effective shelf life of the product. It has now surprisingly been found that these instability and odor problems can be minimized or eliminated by formulating nutritional products with a combination of HMB calcium, CLa and protein. The nutritional products described herein comprise a specific combination of HMB calcium, CLA and protein that not only provides the individual with respect to muscle strength, health and function benefits' but also provides improved physical stability in each of the selected product forms, Sensory and / or aesthetic benefits. [Embodiment] The nutritional product described in this month includes feed and protein. : Equal nutritional products have commercially acceptable taste characteristics and are stable for long periods of time even in liquid form. Some of the characteristics and other features of nutritional products, as well as many of the alternative variations and additions, are described in detail below. π Unless otherwise stated, the term "HMB calcium" as used herein refers to b, β methyl butyrate (also known as hydroxy p-butyric acid, hydroxy _3_: butyl S owing 'β• hydroxy) Calcium salt of valeric acid or hydrazine, which is most commonly present in the form of a single formula. Unless otherwise stated, otherwise used herein to describe the characteristics of the aunt's characteristics, the percentages and concentrations are based on the weight of the calcium monohydrate. . 161134.doc 201233341 The terms "fat" and "oil" as used herein, unless otherwise indicated, are used interchangeably and refer to a lipid material derived from plants or animals or from plants or animals. These terms also include synthetic lipid materials as long as the synthetic materials are suitable for oral administration to humans. The term "storage shelf stability" as used herein means that the nutrient solution is packaged and stored under (4) for at least 3 months (including from about 6 months to about 24, and also includes from about 12 months to about 18). After the month), it remained commercially stable. "Nutritional product" means and is suitable for human mouth. Unless otherwise stated, the term "containing liquids and powders containing protein and one or more fats and carbohydrates for consumption", unless otherwise stated, is used herein. "Nutrition solution" means a nutrient product of the formula (IV) and a nutrient solution prepared by reconstituting the Luyang powder described herein before use. Ratios, parts and ratios are otherwise indicated by the contents, and all percentages used herein are by weight of the total composition, unless otherwise stated. Unless otherwise stated, all such weights as used in the context of the present invention are based on the fact that the active materials may not include solvents or by-products that may be included in the commercially available materials unless otherwise stated or referred to. The context of the plural feature or limitation of the content expressly implies that the content of the singular feature or limitation of the opposite should be construed as the 'or vice versa.' And the context of the combination is expressly implied by the contrary. All combinations of methods or processing steps may be carried out in a sequence unless otherwise stated or modified. 161134.doc 201233341 Various embodiments of the nutritional product of the present invention may also contain no optional or selected essential ingredients or features described herein, provided that the remaining nutritional product still contains as described herein. All the required ingredients or characteristics. Here: In the following, and unless otherwise stated, the term "substantially no choice of nutritional products contains less than the functional amount of the optional ingredients mentioned, 丄^ = the weight of the selected or selected basic ingredients, usually Less than about 1 J A.0/o, including less than about 0.5%, including less than about 〇. 〗 〖%, and also includes 〇%. § Hai and other nutritional products may contain the basic elements of the product as described herein and Any of the additional or optional elements described herein or which may be used in the application of a nutritional product, consist of or consist essentially of the same. Product form The nutritional product of the present invention comprises both liquid and powder forms. The liquid may include solution, suspension Liquids and emulsions. The powders may include any flowable or islandable particulate solids or mirrors which may be diluted with water or other aqueous liquid to form a nutrient solution prior to use. The nutritional products may be formulated with sufficient amounts and amounts of nutrients, To provide a dedicated, primary or supplemental source of nutrition, or to provide specialized nutritional products for individuals with specific diseases or conditions or with targeted nutritional benefits. The compressed or solid nutritional powder, including in the form of a tablet, can be reconstituted by the intended user with a suitable aqueous liquid (usually water or other aqueous liquid) to form a nutrient solution for immediate oral or enteral use. In the meantime, "immediate" use generally means within about 48 hours of reconstitution, more typically within about 24 hours, most commonly immediately after reconstitution, or 161134.doc 201233341 within 20 minutes. The nutritional powders may include spray dried powders, dry mixed powders, and poly
營養液 營養液Nutrient solution
營養液可具有經調整至適合最終使用者營養需求的熱量 密度,但在大多數情形下該等液體包含約1〇〇至約5〇〇 kcal/240 m卜包括約15〇至約35〇 kcai/24〇⑹,且亦包括約 200至約 320 kcal/240 ml。 營養液可具有pH介於約3.5至約8範圍内,但最有利地介 於約4.5至約7.5範圍内,包括約55至約73,包括約62至 約 7.2。 儘管營養液之每份量(serving size)可視許多變數變化, 但典型每份量範圍係約1〇〇 ml至約3〇〇 mi,包括約15〇 ml 至約250 ml ’且亦包括約19〇 m丨至約240 m卜 P-羥基-p甲基丁酸(HMB)約 本文所述之營養產品包含HMB鈣,此意指該等產品由添 加HMB鈣(最通常為單水合物)調配,或以其他方式製備以 161134.doc 201233341 在最終產品中含有鈣及HMB。任何HMB來源均適用於本 文所述之營養產品,條件係最終產品含有鈣及HMB,但該 來源較佳為HMB鈣且最通常在調配期間原樣添加至營養產 品中。 本文所用之術語「所添M2HMB鈣」意指HMB之鈣鹽 (最通常作為HMB之單水合物鈣鹽)作為HMB來源添加至營 養產品中。 儘管HMB鈣單水合物係用於本文之較佳HMB來源,但 其他適宜來源可包括作為游離酸、鹽' 無水鹽、酯、内醋 或以其他方式提供營養產品之HMB之生物可利用形式之其 他產物形式的HMB。用於本文之HMB適宜鹽之非限制性 實例包括鈉、鉀、鎂、鉻、鈣之水合或無水HMB鹽、或其 他無毒性鹽形式。HMB鈣單水合物較佳且可自猶他州鹽湖 城(Salt Lake City,Utah)之國際技源公司(Technical Sourcing International,TSI)購得 ° 以營養液之重量計’營養液中之HMB鈣之濃度範圍可為 至多約10% ’包括約0.01%至約1〇%、且亦包括約〇至約 5.0%、且亦包括約0.5%至約2.0%、且亦包括約〇·4%至約 1.5%。 以營養粉末之重量計’營養粉末中之HMB鈣之濃度範圍 可為至多約10% ’包括約〇.〇1 %至約10%、且亦包括約〇1% 至約7.0%、且亦包括約1.0%至約5_0%、且亦包括約1〇% 至約4.0%。 該%•營養產品可提供每份量(serving)約0.5克至約2.5 161134.doc 201233341 克、包括約1_0克至約1.7克、包括約15克之HMB,其中份 量可介於約100 ml至約400 ml、包括約15〇 mi至約34〇 ml、且亦包括約230 ml至約300 ml營養液之範圍内。份量 可為每天一次、每天兩次、每天三次或更頻繁以獲得期望 量之營養。 共軛亞油酸(CLA)The nutrient solution can have a caloric density adjusted to suit the nutritional needs of the end user, but in most cases the liquid comprises from about 1 Torr to about 5 〇〇 kcal / 240 m b including from about 15 〇 to about 35 〇 kcai /24〇(6), and also includes about 200 to about 320 kcal/240 ml. The nutrient solution can have a pH in the range of from about 3.5 to about 8, but most advantageously in the range of from about 4.5 to about 7.5, including from about 55 to about 73, including from about 62 to about 7.2. Although the serving size of the nutrient solution can vary depending on a number of variables, it is typically in the range of from about 1 〇〇ml to about 3 〇〇mi, including from about 15 〇ml to about 250 ml' and also includes about 19 〇m.丨 to about 240 m P-hydroxy-p-methylbutyric acid (HMB). The nutritional product described herein comprises HMB calcium, which means that the products are formulated by the addition of HMB calcium (most commonly monohydrate), or Prepared in other ways with 161134.doc 201233341 containing calcium and HMB in the final product. Any source of HMB is suitable for use in the nutritional products described herein, provided that the final product contains calcium and HMB, but the source is preferably HMB calcium and is most often added to the nutritional product as it is during formulation. As used herein, the term "added M2HMB calcium" means that the calcium salt of HMB (most commonly as the monohydrate calcium salt of HMB) is added to the nutritional product as a source of HMB. While HMB calcium monohydrate is used in the preferred HMB source herein, other suitable sources may include bioavailable forms of HMB as free acid, salt 'anhydrous salt, ester, internal vinegar, or otherwise providing a nutritional product. Other product forms of HMB. Non-limiting examples of suitable HMB salts for use herein include sodium, potassium, magnesium, chromium, calcium hydrated or anhydrous HMB salts, or other non-toxic salt forms. HMB calcium monohydrate is preferred and available from Technical Sourcing International (TSI) in Salt Lake City, Utah, USA. HMB Calcium in Nutrient Solution, by Weight of Nutrient Solution The concentration range can be up to about 10%, including from about 0.01% to about 1%, and also including from about 5% to about 5.0%, and also including from about 0.5% to about 2.0%, and also including from about 〇4% to about 1.5%. The concentration of HMB calcium in the nutritional powder may range from up to about 10% by weight of the nutritional powder, including from about 1% to about 10%, and also from about 1% to about 7.0%, and also includes From about 1.0% to about 5_0%, and also from about 1% to about 4.0%. The %•nutrition product can provide from about 0.5 grams to about 2.5 161134.doc 201233341 grams per serving, including from about 1_0 grams to about 1.7 grams, including about 15 grams of HMB, wherein the serving may range from about 100 ml to about 400. Ml, including from about 15 〇mi to about 34 〇ml, and also including from about 230 ml to about 300 ml of nutrient solution. The serving size can be once a day, twice a day, three times a day or more frequently to obtain the desired amount of nutrients. Conjugated linoleic acid (CLA)
該等營養產品包含CLA,此意指該等產品藉助添加CLA 加以調配,或以其他方式製備以在最終產品中含有cla。 任一 CLA來源均適用於本文,前提條件係最終產品含有 CLA,但該來源較佳為CLA且最通常在調配期間原樣添加 至營養產品中。 可自市面上購得多種CLA來源以調配至營養產品中,其 中大多數在室溫下呈液體油形式且包含至多1〇〇%、更通 常70-95%之存於油中之CLA。 以營養液之重量計,營養液中之CLA之濃度範圍可為至 多約ίο%,包括約㈣1%至約1G%、且亦包括約〇5%至約 5.0%、且亦包括約1〇%至約3 〇%、且亦包括約ι 至約 2.0% 〇 以營養粉末之重量計,營養粉末中之CLA之濃度範圍可 為至多約10%,包括約0.01%至約10%、且亦包括約〇.5%至 約10.0%、且亦包括約3.0%至約1〇 〇%、且亦包括約3 至約7.0%。 該等營養產品最通常提供每份量自該粉末製備之營 約克至約5·〇克、包括約2 ()克至約4 ()克、包括約^克 161J34.doc 201233341 之 CLA。 在一些貫施例中’營養產品中之CLA及HMB鈣之濃度可 以CLA與HMB鈣之重量比來限定。通常,(:^八與11]^]5鈣之 重置比係約1.2:1.0至約3 〇:1 〇,包括約! 5:1至約2 5:1、包 括約1.8:1至約2.3:1、且進一步包括約18:1至約21:1。 儘管使營養產品具有大於2·丨:丨之(:1^八與HMB鈣之重量比 在本發明之範圍内’但在許多實施例中,可期望具有2.1:1 f更小之CLA與HMB鈣之重量比,以確保在產品中存在足 篁來自HMB約之㉝,以螯合及中和CLA並提供如本文所論 述之改良的物理穩定性。在CLA與HMB鈣之重量比大於 2.1··1之彼等實施例中,在—些實施例中可期望向營養產品 中添加額外鈣來源,以確保在產品中存在足量鈣,由此 CLA被實質上螯合及中和以提供期望之產品物理穩定性。 額外辦來源可包括(例如)氫氧㈣、碳_及/或棒樣酸 鈣。亦可使用諸如氫氧化鎂等其他中和劑。 大量營養素 該等營養產品進-步包含蛋白質,且可除本文所述之 ΗΜΒ約及CLA外視情況包含—或多種其他大量營養素。可 選之大量營養素包括脂質及碳水化合物。 广用於本文之大里營養素包括已知用於口服營養產品中 於口服營養產品中之任一蛋白#、脂質或碳水化合 或“來源’前提條件係可選之大量營養素對於口服投與 ::係安全且有效的,且另外與營養產品中之其他成份相 161134.doc 201233341 營養產品中之可選脂質、碳水化合物及蛋白質的濃度或 量可端視產品之特定營養應用而有相當大的變化。該等可 選大畺營養素最通常在下表中所述之任一所包含範圍内實 施調配。 營養素(佔組合物之wt%)Such nutritional products comprise CLA, which means that the products are formulated by the addition of CLA or otherwise prepared to contain cla in the final product. Any CLA source is suitable for use herein, provided that the final product contains CLA, but the source is preferably CLA and is most commonly added to the nutritional product as it is during the formulation. A variety of CLA sources are commercially available for blending into nutritional products, most of which are in liquid oil form at room temperature and contain up to 1%, more typically 70-95%, of CLA in oil. The concentration of the CLA in the nutrient solution may be in the range of up to about 5%, including about (4) 1% to about 1%, and also including about 5% to about 5.0%, and also including about 1%. Up to about 3%, and also including from about 1 to about 2.0%. The concentration of CLA in the nutritional powder may range from up to about 10%, including from about 0.01% to about 10%, and also includes, by weight of the nutritional powder. It is from about 5% to about 10.0%, and also includes from about 3.0% to about 1%, and also includes from about 3 to about 7.0%. Such nutritional products most typically provide a CLA of from y York to about 5 grams per gram of preparation of the powder, including from about 2 () grams to about 4 (grams), including about gram 161 J34.doc 201233341. In some embodiments, the concentration of CLA and HMB calcium in the nutritional product can be defined by the weight ratio of CLA to HMB calcium. Usually, the reset ratio of (:^8 and 11]^]5 calcium is about 1.2:1.0 to about 3 〇:1 〇, including about! 5:1 to about 2 5:1, including about 1.8:1 to about 2.3:1, and further comprising from about 18:1 to about 21:1. Although the nutritional product has a weight ratio greater than 2: 丨: 1 (: 1^8 and HMB calcium is within the scope of the invention 'but in many In embodiments, it may be desirable to have a weight ratio of CLA to HMB calcium of 2.1:1 f to ensure that there is sufficient sputum from the HMB in the product to sequester and neutralize the CLA and provide as discussed herein. Improved physical stability. In embodiments in which the weight ratio of CLA to HMB calcium is greater than 2.1··1, it may be desirable in some embodiments to add additional sources of calcium to the nutritional product to ensure the presence of sufficient foot in the product. The amount of calcium, whereby the CLA is substantially chelated and neutralized to provide the desired physical stability of the product. Additional sources may include, for example, oxyhydrogen (tetra), carbon _ and/or calcium sulphate. Hydrogen such as hydrogen may also be used. Other neutralizing agents such as magnesium oxide. Nutrients Nutrients These nutritional products further contain proteins and can be packaged in addition to the protocol and CLA external conditions described herein. - or a variety of other macronutrients. Optional macronutrients include lipids and carbohydrates. The large nutrients commonly used herein include any of the proteins known to be used in oral nutritional products in oral nutritional products #, lipids or carbohydrates or The “source” precondition is an optional large amount of nutrients for oral administration:: is safe and effective, and additionally with other ingredients in the nutritional product. 161134.doc 201233341 Optional lipids, carbohydrates and proteins in nutritional products The concentration or amount may vary considerably depending on the particular nutritional application of the product. These optional large nutrients are most commonly formulated within any of the ranges described in the table below. Nutrients (wt% of composition) )
每一數值前面均有術語 營養素(佔總熱量之%) 實例A 實例B 破水化合物 0-100 H 10-70 脂質 20-65 蛋白質 0-100 5-40 實例c_ 40-5(Γ 35-55 15-25' 每一數值前面均有術語 蛋白質 營養產品進一步包含蛋白質。適用於口服營養產品且盥 該等產品之基本要素及特徵相容之任—蛋白質或其來源^ 係適宜的。 :營養液之重量計’營養液中之蛋白質之濃度可 W至約概範圍内,包括約哪至約15%、且亦包 1%至約10%、且亦包括約i 〇%至約7 。 對於粉末實施例,以.營養粉末 $里叶,蛋白質之濃声 可”於約1.0。/。至約50。/〇範圍内’句括 又 .,, I括約10%至約50%、且 亦包括約10%至約30%。 用於營養產品之適宜蛋白質戈盆來 t 、木/原之非限制性實伽七 括經水解、部分經水解或未經 貫例包 蛋白質或蛋白質來 161134.doc -12· 201233341 源’其可來源於任一已知岑土商眘氺 次適且來源,例如乳(例如, 蛋白、乳清)、動物(例如,肉、魚)、毅類(例如,稻米、 玉米)、蔬菜(例如’大豆或婉幻或其組合。該等蛋白質之 非限制性實例包括乳蛋白分離物、乳蛋白濃縮物、路蛋白 分離物、乳清蛋白、酪蛋白鈉或酪蛋白鈣、全脂牛乳、部 分或完全脫脂乳、大豆蛋白分離物、大豆蛋白濃縮物等。 在-個實施例中,蛋白質系統包括至少約5〇%之酪蛋白 鈉、合意地至少約60%之酪蛋㈣、合意地至少約7〇%之 酪蛋白鈉、合意地至少約80%之酪蛋白鈉、合意地至少約 90%之酪蛋白鈉或合意地至少約1〇〇%之酪蛋白鈉。 在另一具體貫施例中,蛋白質系統包括蛋白質來源之組 合,包括酪蛋白鈣(或酪蛋白鈉)及大豆蛋白分離物。在另 一具體實施例中,蛋白質系統包括蛋白質來源之組合,包 括酿蛋白鈉(或酪蛋白鈣)、乳蛋白濃縮物、大豆蛋白分離 物及乳清蛋白濃縮物。 碳水化合物 營養產品可進一步包含適用於口服營養產品且與該等產 品之基本要素及特徵相容之任何碳水化合物。 以營養液之重量計,營養液中之碳水化合物之濃度可 (例如)介於約5.0%至約40%範圍内,包括約7.0%至約 30%、包括約10%至約25% »在一個具體實施例中,碳水 化合物以佔營養液重量之約10.2%的量存在於營養液中。 以營養固體之重量計,營養固體中之碳水化合物之濃度 可介於約10%至約90%範圍内,包括約20%至約80%、進一 161134.doc -13- 201233341 步包括約40%至約6G%。在—個具體實施例中,碳水化合 物以佔營養固體重量之約58%的量存在於營養固體中。 用於本文所述之營養產品中之適宜碳水化合物或其來源 之非限制性實例可包括麥芽糊精、經水解或經改質澱粉或 玉米澱粉、葡萄糖聚合物、玉米激、玉米毁固體 '源自稻 米之碳水化合物、蔗糖、葡萄糖、果糖、乳糖、高果糖玉 米漿蜂®才唐醇(例如,麥芽糖醇、赤藻糖醇、山梨糖 醇)、人工甜味劑(例如U素、乙酿舒泛钟…繼 potassium)、甜菊)及其组合。尤其期望之碳水化合物係低 右旋糖當量(DE)麥芽糊精。 在-個具體實施例中,碳水化合物系統包括碳水化合物 來源之組合,包括麥芽糊精(視情況低DE麥芽糊精)及嚴 脂肪 最通常呈乳化脂肪形式。 品之基本要素及特徵相容 營養產品可進一步包含脂肪, 適用於口服營養產品且與該等產 之任一脂肪均係適宜的。 以營養液之重量計,脂肪可以約1()%至約鄕、包括約 1.0%至約20%、且亦包括約i 〇%至約15%、且亦包括約 】篇至約5.0%之量存在於營養液中。在一㈣體實施例 中,營養液包括佔營養液重量之約16%之量的脂肪。 以營養固體之重量計,脂肪可以約1〇%至約3〇%、包括 約U%至約20%、且亦包括約咖至約15%、且亦包括約 5.0%至約1G%之量存在於營養固體中。在—個具體實施例 161134.doc 201233341 中’營養固體包括佔營養固體重量之約7.5%之量的脂肪。 用於本文之適宜脂肪來源包括適用於口服營養產品且與 該等產品之基本要素及特徵相容之任一脂肪或脂肪來源。 用於本文所述之營養乳液中之適宜脂肪或其來源之非限 • 制性實例包括椰子油、分餾椰子油、大豆油、玉米油、撖 . 欖油、紅花油、高油酸紅花油、MCT油(中長鏈三酸甘油 适曰)、向日葵油、高油酸向日葵油、棕櫚油及棕橺仁油、 棕櫚油精、芥花油(can〇la 〇⑴、海產油、棉籽油及其組 合0 在一個具體實施例中,脂肪系統包括脂肪來源之組合, 包括高油酸紅花油、芥花油及大豆油。 製造方法 營養液可藉由用於製造營養液(包括乳液,例如基於乳 之營養乳液)之任一已知或適宜方法來製造。 在一種適宜製造方法中,營養液係使用至少三種各別漿 液製備’包括蛋白質於脂肪中之⑽)聚液、碳水化合物_ 礦物質(CHO-MIN)襞液及蛋白質於水中之(piw)聚液。pIF 聚液係由加熱及混合所選之油(例如芬花油、玉米油等)及 ' 隨後在連續加熱及攪拌下添加乳化劑(例如印磷脂)、脂溶 陡維生素及總蛋白質之一部分(例如乳蛋白濃縮物等)形 成。CHO-MIN聚液係由在加熱攪拌下向水中添加以下物質 形成:礦物質(例如棒檬酸_、磷酸氣二卸、捧樣酸鈉 等)、痕量及超痕量礦物質(TM/UTM預混合物)、增稠劑或 懸浮劑(m口艾維素微晶纖維素(Avicel)、結蘭膠(geiian)、 161134.doc 201233341 卡拉膠(carrageenan))、及HMB鈣及CLA。將所得CHO- MIN漿液在連續加熱及攪拌下保持1〇分鐘,然後添加其他 礦物質(例如氯化鉀、碳酸鎂、碘化鉀等)、碳水化合物(例 如寡果糖(fructooligosaccharide)、蔗糖、玉米聚等)。然 後,藉由在加熱及攪拌下將剩餘蛋白質(例如酪蛋白鈉、 大豆蛋白濃縮物等)混合至水中形成pIW漿液。 然後所得漿液在加熱攪拌下摻合在一起,並將pH調節至 '月望範圍(通常為6.6-7·0),然後組合物經高溫短時(HTS丁) 處理,期間組合物經加熱處理、乳化及均質化,然後冷 部。添加水浴性維生素及抗壞血酸,再將pH調節至期望範 圍(若需要),添加香料,並添加水以達到期望之總固體含 量。然後無菌包裝、组合物以形成無菌包裝之營養乳液,或 將”且口物添加至殺菌釜穩定容器中且然後經殺菌釜滅菌以 形成經殺菌釜滅菌之營養乳液。 s養乳液之t造方法可以不同於本文所述而不背離本發 明精神及範圍之方式實施。因此’本發明實施例在所有態 樣+應視為例示性而非限制十生,且所有變化及相等物亦在 本發明之說明内。 營養固體(例如喷霧乾燥營養粉末)可藉由適於製造及調 配喷霧乾燥營養粉末之已知或其他有效技術之任何集合製 備0 1霧乾燦步驟同;):笔·Aj 0 > J樣了包括已知用於產生營養粉末或適用 於產生營養粉末之任一喑 赁霧乾煤技術。已知許多不同噴靈 乾燥方法及技術可用於A盖 、 用於營養領域,所有該等方法及技術均 ϊ 6ϊ 134.doc -16- 201233341 適用於製造本文之喷霧乾燥營養粉末。 種氣備喷轉乾燥營養粉末之方法包含形成包含ΗΜΒ、 八及蛋白質、以及視情況碳水化合物及脂肪之水性漿液 或液體並均質化’且隨後將漿液或液體喷霧乾燥以產生喷 霧乾燥營養粉末。財法可進—步包含㈣乾燥、幹式混 合或將額外營養成份(包括本文所述成份中之任-或多者) 添加至嘴霧乾燥營養粉末中之步驟。 °亥等製造方法較佳以ΗΜΒ鈣(其最通常作為HMB鈣單水 〇物進仃調配)作為用於該等方法中之HMB來源進行調 配。 可選成份 、本文所述之營養產品可進一步包含其他可選成份,當用 :目私人群時,其可改變產品之物理、營養、化學、愉悅 或處理特徵或肖作醫藥或額外營養組份^許多該等可選成 伤係已知或適宜用於其他營養產品中,且亦可用於本文所 v s養產βσ中,則提條件係該等可選成份對於口服投與 而吕安全且有效且與所選產品形式中之基本及其他成份相 容。 該等可選成份之非限制性實例包括防腐劑、抗氧化劑、 乳化劑、緩衝劑、寡果糖…比咬甲.酸絡(山⑽ P · Unate) ^藥活性物質、如本文所述之額外營養素、 著色劑、香料、増稠劑及穩定劑等。 该等產品可進一步包含維生素或相關營養素,其非限制 性實例包括維生素A、維生素D、維生素E、維生素κ、硫 161134.doc •17- 201233341 胺素、核黃素…"醇、維生素B12、類胡蘿㈣、於驗 酸、葉酸、泛酸、生物素、維生素c、膽驗、肌醇、其鹽 及衍生物、及其組合。 4等產可進-步包含礦物質,其非限制性實例包括 破鎮好、鐵、鋅、猛、銅、_、_、#、^ 1 化物及其組合。 該等產品亦可包括-或多種橋味劑或掩蓋劑。適宜之橋 味劑或掩蓋劑包括天然及人工甜味劑、鈉來源(例如氣化 鈉)、及親水膠體(例如瓜爾膠(guar gum)、三仙膠(xanthan gum)、卡拉膠、結蘭膠(㈣丨⑽gum)、阿拉伯膠㈣爪 acacia))及其組合。 使用方法 該等營養產品可在個體及運動M Μ作營養來源以及幫 助促進健康肌肉之形成及維持、以及用於增強表現耐力。 另外’該等營養產品可尤其適宜用於需要維持健康肌肉質 量、力量及功能之年老及老年個體。該等營養產品可有助 於減輕年老成人之虛弱並改良肌肉張力。 該等方法進—步旨在在投與該等產品後、最通常在經約 1個月至約6個月(包括約1個月至約3個月)之較長時間段每 天使用後為個體提供以下各項中之一或多去. 7 4 , 1 )又持瘦體 質之維持及生長,2)支持力量及/或肌肉力量之維持及増 長’ 3)減少蛋白質分解及肌細胞損傷’ 4)促進锻練或其^ 創傷後之肌肉恢復,及5)減少鍛煉後之肌肉蛋白質八解 實例 161134.doc 18 201233341 以下實例闡釋本發明營養產品之具體實施例及或特 該等實例僅出於闡釋之目的給出以應將其理解為對^ 明之限制’此乃因在不背離本發明精神及範圍之情形下其 可有許多變化形式。除非另有說明,否則所有例示之量皆 係基於組合物總重量之重量百分比。 /斤例示組合物係可按照營養工業中熟知之用於製備營養 礼液及喷霧乾燥營養粉末之製造方法製備之營養產品。 實例1-5 實】5闡釋包括1詞、CLA及蛋白質之本發明營養 粉末’其成份列示於下表中。料產品可藉由喷霧乾燥方 法以單㈣次來製備,且可在制前时重構錢望目標 成份濃度°除非另有說明,否則所有成份量均以kgmoo kg 一批產品列出。 ~~--- 麥芽糊精---- 實例1 實例2 A"iii η 實例3 實例4 實例5~] 蔗糖__~~~----- 酪蛋白約 —--- • 0 0 · / 145.5 145.5 436.7 145.5 436.7 145.5 436.7 145.5 ~ "CLA ------ 129.1 129.1 129.1 129.1 129.1 分離的大丑-------- 67.0 63.65 70.35 60.3 73.7 FOS 粉末 '----- 57.7 57.7 57.7 61.7 57.7 HO向日葵i ~~~-- 33.6 33.6 33.6 33.6 32.6 HMB 鈣 --—~~~-_ 33.1 30.1 36.1 33.1 33.1 芬花油 " *---- 31.6 34.6 28.6 27.6 32.6 ~ 大豆油~~" '—--- 28.3 28.3 28.3 28.3 28.3 檸檬酸鉀 ~~~~'------ 13.3 13.3 Γ 13.3 13.3 13.3 檸檬酸鈉 ·~~~--- 10.3 10.3 10.3 10.3 10.3 氣化鉀 ~---- 5.8 5.8 5.8 5.8 5.8 氯化鎂 ~·~—--- 5.2 5.2 5.2 5.2 5.2 氩氧化鉀 '~·~----- 4.7 4.7 4.7 4.7 4.7 填酸氮一納三-—~~-— 3.1 3.1 3.1 3.1 3.1 ------— ^ 〇 切 氣化鈉 —_ 3.0 3.0 3.0 3.0 3.0 氣化膽驗 —-— 2.5 2.5 2.5 2.5 2.5 " —~~~~~~_ 1.8 1.8 1.8 1.8 1.8 161134.doc •19· 201233341Each value is preceded by the term nutrient (% of total calories). Example A Example B Water-breaking compound 0-100 H 10-70 Lipid 20-65 Protein 0-100 5-40 Example c_ 40-5 (Γ 35-55 15 -25' Each value is preceded by the term protein nutritional product further comprising protein. Suitable for oral nutritional products and compatible with the essential elements and characteristics of such products - protein or its source ^ suitable for: nutrient solution The concentration of the protein in the nutrient solution can range from about to about 15%, and also from about 1% to about 10%, and also from about i% to about 7. For powder implementation. For example, the nutrient powder can be used in the range of about 1.0% to about 50%, and the range of about 10% to about 50%, and includes From about 10% to about 30%. Suitable protein for nutritional products, Goba to t, wood/original non-restrictive gamma, hydrolyzed, partially hydrolyzed or uncontained protein or protein 161134.doc -12· 201233341 Source 'It can be derived from any known cultivator, cautious and appropriate source, such as milk ( For example, protein, whey), animals (eg, meat, fish), Yi (eg, rice, corn), vegetables (eg 'soy or illusion or combinations thereof. Non-limiting examples of such proteins include milk proteins Isolate, milk protein concentrate, road protein isolate, whey protein, casein sodium or casein calcium, whole fat cow's milk, partially or complete skim milk, soy protein isolate, soy protein concentrate, etc. In one embodiment, the protein system comprises at least about 5% sodium caseinate, desirably at least about 60% casein (four), desirably at least about 7% sodium caseinate, desirably at least about 80% sodium caseinate, Desirably at least about 90% sodium caseinate or desirably at least about 1% sodium caseinate. In another specific embodiment, the protein system comprises a combination of protein sources, including casein calcium (or casein sodium). And a soy protein isolate. In another specific embodiment, the protein system comprises a combination of protein sources, including brewed protein sodium (or casein calcium), milk protein concentrate, soy protein isolate, and whey egg The carbohydrate nutritional product may further comprise any carbohydrate suitable for oral nutritional products and compatible with the essential elements and characteristics of the products. The concentration of carbohydrates in the nutrient solution may be based on the weight of the nutrient solution (eg ) ranging from about 5.0% to about 40%, including from about 7.0% to about 30%, including from about 10% to about 25%. In a particular embodiment, the carbohydrate is about 10.2% by weight of the nutrient solution. The amount is present in the nutrient solution. The concentration of the carbohydrate in the nutrient solids may range from about 10% to about 90%, including from about 20% to about 80%, and further into 161134.doc-13. - 201233341 Steps include approximately 40% to approximately 6G%. In a specific embodiment, the carbohydrate is present in the nutritional solids in an amount of about 58% by weight of the nutritional solids. Non-limiting examples of suitable carbohydrates or sources thereof for use in the nutritional products described herein can include maltodextrin, hydrolyzed or modified starch or corn starch, glucose polymer, corn agglutination, corn smashed solids' From rice carbohydrates, sucrose, glucose, fructose, lactose, high fructose corn syrup bees® (eg, maltitol, erythritol, sorbitol), artificial sweeteners (eg U, B) Stuffed with a bell... followed by potassium), stevia, and combinations thereof. Particularly desirable carbohydrates are low dextrose equivalent (DE) maltodextrin. In a specific embodiment, the carbohydrate system comprises a combination of carbohydrate sources, including maltodextrin (as appropriate, low DE maltodextrin) and stringent fat, most commonly in the form of emulsified fat. The basic elements and characteristics of the product are compatible. The nutritional product may further comprise fat, which is suitable for oral nutritional products and is suitable for any of these fats. The fat may be from about 1% to about 5%, including from about 1.0% to about 20%, and also from about 9% to about 15%, and also from about 5% to about 5.0% by weight of the nutrient solution. The amount is present in the nutrient solution. In one (four) embodiment, the nutrient solution comprises a fat in an amount of about 16% by weight of the nutrient solution. The fat may be from about 1% to about 3% by weight, including from about U% to about 20%, and also from about 5% to about 15%, and also from about 5.0% to about 1% by weight, based on the weight of the nutritional solids. Present in nutritive solids. In a specific embodiment 161134.doc 201233341 'nutritional solids include fat in an amount of about 7.5% by weight of the nutritional solids. Suitable fat sources for use herein include any fat or fat source suitable for use in oral nutritional products and compatible with the essential elements and characteristics of such products. Non-limiting examples of suitable fats or sources thereof for use in the nutritional emulsions described herein include coconut oil, fractionated coconut oil, soybean oil, corn oil, alfalfa oil, safflower oil, high oleic safflower oil, MCT oil (medium long chain triglyceride), sunflower oil, high oleic sunflower oil, palm oil and palm kernel oil, palm olein, canola oil (can〇la 〇 (1), seafood oil, cottonseed oil and Combination 0 In a specific embodiment, the fat system comprises a combination of fat sources, including high oleic safflower oil, canola oil, and soybean oil. Manufacturing Method The nutrient solution can be used to make a nutrient solution (including an emulsion, for example based on Any known or suitable method of making a nutritional emulsion of milk. In a suitable manufacturing method, the nutrient solution uses at least three separate slurries to prepare a liquid (including protein (10)), a carbohydrate, a mineral. (CHO-MIN) sputum and protein (piw) poly-liquid in water. The pIF liquid system consists of heating and mixing selected oils (such as fennel oil, corn oil, etc.) and then adding emulsifiers (such as imprinted phospholipids), fat-soluble steep vitamins and total protein in continuous heating and stirring ( For example, milk protein concentrates, etc. are formed. CHO-MIN liquid system is formed by adding the following substances to water under heating and stirring: minerals (such as citric acid _, phosphoric acid gas unloading, sodium sulphate, etc.), trace and ultra-trace minerals (TM/ UTM premix), thickener or suspending agent (Avicel microcrystalline cellulose (Avicel), gelatin (geiian), 161134.doc 201233341 carrageenan), and HMB calcium and CLA. The obtained CHO-MIN slurry is kept under continuous heating and stirring for 1 minute, and then other minerals (such as potassium chloride, magnesium carbonate, potassium iodide, etc.), carbohydrates (such as fructooligosaccharide, sucrose, corn poly, etc.) are added. ). Then, the pIW slurry is formed by mixing the remaining protein (e.g., casein sodium, soy protein concentrate, etc.) into water under heating and stirring. The resulting slurry is then blended together under heat and agitation, and the pH is adjusted to the 'monthly range (usually 6.6-7. 0), and then the composition is treated with high temperature for a short time (HTS), during which the composition is heat treated. , emulsification and homogenization, then cold. The water-bath vitamins and ascorbic acid are added, the pH is adjusted to the desired range (if needed), the perfume is added, and water is added to achieve the desired total solids content. The composition is then aseptically packaged, formed into a sterile packaged nutritional emulsion, or "and the mouthpiece is added to a sterilizer stable container and then sterilized by a sterilizer to form a sterilized sterilized nutritional emulsion. The invention may be practiced otherwise than as described herein without departing from the spirit and scope of the invention. The present invention is to be considered as illustrative and not limiting, and all changes and equivalents are also in the invention. The nutrient solids (e.g., spray-dried nutritional powders) can be prepared by any combination of known or other effective techniques suitable for making and formulating spray-dried nutritional powders. Aj 0 > J-like includes any of the dry-coal dry coal technologies known to be used to produce nutritional powders or for the production of nutritional powders. Many different spray drying methods and techniques are known for use in A-covers, in the field of nutrition. , all such methods and techniques are ϊ 6ϊ 134.doc -16- 201233341 Suitable for the manufacture of spray-dried nutritional powders herein. The method for preparing a gas-sprayed dry nutritional powder comprises forming An aqueous slurry or liquid comprising hydrazine, octa and protein, and optionally carbohydrates and fats, and homogenized' and then spray-dried the slurry or liquid to produce a spray-dried nutritional powder. The method of financing may include (iv) drying, Dry mixing or the step of adding additional nutrients (including any one or more of the ingredients described herein) to the mouth-dried nutrient powder. The method of manufacturing is preferably strontium calcium (which is most commonly used as HMB calcium). The monohydrate feeds are blended as a source of HMB for use in such methods. The optional ingredients, the nutritional products described herein may further comprise other optional ingredients which may be changed when used in a private group. The physical, nutritional, chemical, pleasure or handling characteristics of the product or the medicinal or additional nutritional components of the product. Many of these optional wounds are known or suitable for use in other nutritional products and can also be used for the maintenance of the products in this article. In βσ, it is stated that these optional ingredients are safe and effective for oral administration and are compatible with the essential and other ingredients in the selected product form. Restrictive examples include preservatives, antioxidants, emulsifiers, buffers, oligofructose, bismuth, acid (Mountain (10) P · Unate) ^ pharmaceutically active substances, additional nutrients as described herein, colorants, flavors, Thickeners, stabilizers, etc. These products may further contain vitamins or related nutrients, non-limiting examples of which include vitamin A, vitamin D, vitamin E, vitamin κ, sulfur 161134.doc • 17- 201233341 Amine, nuclear yellow素..."alcohol, vitamin B12, carotenoid (four), acid test, folic acid, pantothenic acid, biotin, vitamin C, biliary test, inositol, its salts and derivatives, and combinations thereof. The step comprises minerals, non-limiting examples of which include broken towns, iron, zinc, lanthanum, copper, _, _, #, ^1 compounds, and combinations thereof. These products may also include - or a plurality of bridge or masking agents. Suitable bridging agents or masking agents include natural and artificial sweeteners, sodium sources (such as sodium carbonate), and hydrophilic colloids (such as guar gum, xanthan gum, carrageenan, knots). Lacquer ((iv) 丨 (10) gum), gum arabic (four) claw acacia) and combinations thereof. HOW TO USE These nutritional products can be used as a source of nutrition in individuals and sports M and help promote the formation and maintenance of healthy muscles and to enhance performance endurance. In addition, these nutritional products are particularly suitable for elderly and elderly individuals who need to maintain healthy muscle mass, strength and function. These nutritional products can help alleviate the weakness of older adults and improve muscle tone. The methods are intended to be used after each day of administration, most often after a period of from about 1 month to about 6 months (including about 1 month to about 3 months). Individuals provide one or more of the following: 7 4 , 1 ) Maintaining and growing lean body, 2) Supporting strength and/or maintenance of muscle strength and '3' reducing protein breakdown and muscle cell damage' 4) promoting exercise or muscle recovery after trauma, and 5) reducing muscle protein after exercise. Example 161134.doc 18 201233341 The following examples illustrate specific embodiments of the nutritional products of the present invention and or It is intended that the scope of the invention be construed as being limited by the scope of the invention. All exemplified amounts are by weight based on the total weight of the composition, unless otherwise stated. The exemplified composition is a nutritional product prepared by a manufacturing method well known in the nutrition industry for preparing a nutrient solution and a spray-dried nutritional powder. Examples 1-5 Real 5 explains the nutritional powder of the present invention comprising 1 word, CLA and protein. The ingredients thereof are listed in the following table. The product can be prepared in a single (four) times by spray drying, and the target concentration can be reconstituted before preparation. Unless otherwise stated, all ingredients are listed in a batch of kgmoo kg. ~~--- Maltodextrin---- Example 1 Example 2 A"iii η Example 3 Example 4 Example 5~] Sucrose __~~~----- Casein A---- • 0 0 · / 145.5 145.5 436.7 145.5 436.7 145.5 436.7 145.5 ~ "CLA ------ 129.1 129.1 129.1 129.1 129.1 The big ugly separation --- 67.0 63.65 70.35 60.3 73.7 FOS powder '----- 57.7 57.7 57.7 61.7 57.7 HO sunflower i ~~~-- 33.6 33.6 33.6 33.6 32.6 HMB Calcium---~~~-_ 33.1 30.1 36.1 33.1 33.1 Fenhua oil" *---- 31.6 34.6 28.6 27.6 32.6 ~ Large Soybean oil ~~" '---- 28.3 28.3 28.3 28.3 28.3 Potassium citrate~~~~'------ 13.3 13.3 Γ 13.3 13.3 13.3 Sodium citrate·~~~--- 10.3 10.3 10.3 10.3 10.3 Vaporized potassium~---- 5.8 5.8 5.8 5.8 5.8 Magnesium chloride~·~---- 5.2 5.2 5.2 5.2 5.2 Potassium argon oxide '~·~----- 4.7 4.7 4.7 4.7 4.7 Filling acid nitrogen one nano-three —~~-— 3.1 3.1 3.1 3.1 3.1 ------— ^ 〇切化化化-_ 3.0 3.0 3.0 3.0 3.0 Gasification biliary test ——— — 2.5 2.5 2.5 2.5 2.5 " —~~~~~ ~_ 1.8 1.8 1.8 1.8 1.8 161134.doc •19· 201233341
香草香料 1.8 1.8 1.8 1.8 1.8 磷酸二氫鈉單水合物 1.6 1.6 1.6 1.6 1.6 磷酸氫二鉀三水合物 1.1 1.1 1.1 1.1 1.1 香料 1.0 1.0 1.0 1.0 1.0 維生素預混合物 1.0 1.0 1.0 1.0 1.0 抗壞血酸棕櫊酸酯 0.243 0.243 0.243 0.243 0.243 抗壞血酸 0.240 0.240 0.240 0.240 0.240 抗氧化劑 0.116 0.116 0.116 0.116 0.116 硫酸亞鐵 0.092 0.092 0.092 0.092 0.092 維生素預混合物 0.065 0.065 0.065 0.065 0.065 硫酸鋅單水合物 0.057 0.057 0.057 0.057 0.057 硫酸猛 0.045 0.045 0.045 0.045 0.045 礦物質混合物硫酸銅 0.035 0.035 0.035 0.035 0.035 B胡蘿蔔素 0.005 0.005 0.005 0.005 0.005 氯化鉻 0.001 0.001 0.001 0.001 0.001 在目酸納 0.0012 0.0012 0.0012 0.0012 0.0012 蛾化鉀 0.001 0.001 0.001 0.001 0.001 亞硒酸鈉 0.0004 0.0004 0.0004 0.0004 0.0004 檸檬酸 AN AN AN AN AN 氫氧化鉀 AN AN AN AN AN 乾燥硫酸鎮 AN AN AN AN AN 超微粉化磷酸三鈣 AN AN AN AN AN 抗壞血酸 AN AN AN AN AN AN=根據需要 實例6-10 實例6-10闡釋本發明之營養乳液實施例,其成份在下表 中列出。除非另有說明,否則所有量均以公斤/1000公斤 一批產品列出。 成份 實例6 實例7 實例8 實例9 實例10 水 適量 適量 適量 適量 適量 蔗糖 89.3 89.3 89.3 89.3 89.3 麥芽糊精 29.7 29.7 29.7 29.7 29.7 酪蛋白鈉 25.9 25.9 25.9 25.9 25.9 乳蛋白濃縮物 19.1 19.1 19.1 19.1 19.1 CLA 14.2 13.5 14.9 12.8 15.6 大豆蛋白分離物 11.9 11.9 9.9 12.9 13.9 檸檬酸鉀 7.9 7.9 7.9 7.9 7.9 大豆油 6.4 5.4 6.4 6.4 6.4 HMB鈣 6.7 7.7 8.7 5.7 4.7 161134.doc -20· 201233341 茶花油 5.5 5.5 5.5 5.5 5.5 玉米油 4.6 4.6 4.6 4.6 4.6 乳清蛋白濃縮物 3.5 3.5 3.5 3.5 3.5 磷酸氫鎂 3.1 3.1 3.1 3.1 3.1 香料 2.0 2.0 2.0 2.0 2.0 微晶纖維素 2.0 2.0 2.0 2.0 2.0 大豆卵磷脂 1.5 1.5 1.5 1.5 1.5 磷酸氫二鈉二水合物 1.3 1.3 1.3 1.3 1.3 磷酸氫二鉀 0.985 0.985 0.985 0.985 0.985 氯化鉀 0.729 0.729 0.729 0.729 0.729 氯化膽鹼 0.480 0.480 0.480 0.480 0.480 抗壞血酸 0.469 0.469 0.469 0.469 0.469 碳酸鈣 0.451 0.451 0.451 0.451 0.451 焦糖香料 0.450 0.450 0.450 0.450 0.450 奶精 0.450 0.450 0.450 0.450 0.450 UTM/TM預混合物 0.367 0.367 0.367 0.367 0.367 45%氫氧化鉀 0.323 0.323 0.323 0.323 0.323 卡拉膠 0.200 0.200 0.200 0.200 0.200 水溶性維生素預混合物 0.185 0.185 0.185 0.185 0.185 維生素DEK預混合物 0.067 0.067 0.067 0.067 0.067 氯化鈉 0.060 0.060 0.060 0.060 0.060 結蘭膠 0.050 0.050 0.050 0.050 0.050 維生素A棕櫊酸酯 0.0082 0.0082 0.0082 0.0082 0.0082 玉米油載劑 適量 適量 適量 適量 適量 維生素d3 399 mg 399mg 399 mg 399 mg 399 mg 碘化鉀 194 mg 194mg 194 mg 194 mg 194 mg 實例11 在此實例中,分析包括CLA、HMB及蛋白質之營養乳液 之穩定性,並與不含CLA之對照試樣乳液進行比較。 用於對照試樣營養乳液及包括CLA之營養乳液二者的調 配物闡述於下表中。除非另有說明,否則所有成份量均以 公斤/1000公斤一批產品列出。該等乳液係使用本文所述 之常用方法來製備。 成份 對照 含有CLA之乳液 水 適量 適量 蔗糖 89.3 89.3 161134.doc •21 - 201233341 麥芽糊精 29.7 29.7 路蛋白納 25.9 25.9 乳蛋白濃縮物 19.1 19.1 CLA 0.0 14.2 大豆蛋白分離物 11.9 11.9 檸檬酸鉀 7.9 7.9 大豆油 6.4 6.4 HMB鈣 6.7 6.7 芥花油 5.5 5.5 玉米油 4.6 4.6 乳清蛋白濃縮物 3.5 3.5 磷酸氫鎂 3.1 3.1 香料 2.0 2.0 微晶纖維素 2.0 2.0 大豆卵磷脂 1.5 1.5 磷酸氫二鈉二水合物 1.3 1.3 填酸氫二鉀 0.985 0.985 氯化鉀 0.729 0.729 氣化膽鹼 0.480 0.480 抗壞血酸 0.469 0.469 碳酸鈣 0.451 0.451 香料 0.450 0.450 奶精 0.450 0.450 UTM/TM預混合物 0.367 0.367 45%氫氧化if 0.323 0.323 卡拉膠 0.200 0.200 水溶性維生素預混合物 0.185 0.185 維生素DEK預混合物 0.0675 0.067 氣化鈉 0.0601 0.060 結蘭膠 0.0500 0.050 維生素A棕橺酸酯 0.0082 0.0082 玉米油(載劑) 適量 適量 維生素d3 399 mg 399 mg 蛾化飾 194.4 mg 194.4 mg 將營養乳液包裝於240-ml塑膠容器中並使用常用方法進 行殺菌釜滅菌。目測檢查令人驚奇地顯示,在環境溫度下 儲存12個月後,包括CLA及HMB鈣之營養乳液與包括HMB 鈣但不包括CLA之對照相比顯示較少沈積物(見圖1 ;左側 為對照試樣且右側為含有CLA之乳液)。換言之,營養乳 161134.doc -22- 201233341 液中包括CLA令人驚奇地改良含有HMB鈣之營養產品12個 月後之物理穩定性,此乃因在容器底部形成及沉降顯著較 少之沉澱。 實例12 在此實例中’針對味道品質對實例丨丨之包括CLA、HMB 約及蛋白質之營養乳液及未添加CLA之對照試樣進行分 析。具體而言,由於CLA提供苦味且在直接攝取後賦予強 烈咽喉刺激,故難以在不將產品味道顯著損害至商業上不 期望之程度的情況下將此功能成份納入營養產品中。 由經§;丨丨練感官組(traine(j sensory panel)針對各種味道之 強度對試樣乳液進行分析:甜味、鹹味、酸味、苦味、氣 未強度(flavor intensity)、驗味強度(base intensity)及盼 味。具體而言’在製備乳液後,5名經訓練小組成員食用8 液量盘斯(fluid ounce)之每一營養乳液。食用每—乳液 後,每一小組成員使用下表中所列之分析工具(pr〇filer)給 味道評定等級。隨後取結果之平均值。Vanilla Spice 1.8 1.8 1.8 1.8 1.8 Sodium Dihydrogen Phosphate Monohydrate 1.6 1.6 1.6 1.6 1.6 Dipotassium Hydrogen Phosphate Trihydrate 1.1 1.1 1.1 1.1 1.1 Perfume 1.0 1.0 1.0 1.0 1.0 Vitamin Premix 1.0 1.0 1.0 1.0 1.0 Ascorbate 0.243 0.243 0.243 0.243 0.243 Ascorbic acid 0.240 0.240 0.240 0.240 0.240 Antioxidant 0.116 0.116 0.116 0.116 0.116 Ferrous sulfate 0.092 0.092 0.092 0.092 0.092 Vitamin premix 0.065 0.065 0.065 0.065 0.065 Zinc sulfate monohydrate 0.057 0.057 0.057 0.057 0.057 Sulfuric acid 0.045 0.045 0.045 0.045 0.045 Mineral mixture copper sulfate 0.035 0.035 0.035 0.035 0.035 B carotene 0.005 0.005 0.005 0.005 0.005 Chromium chloride 0.001 0.001 0.001 0.001 0.001 In the case of sodium citrate 0.0012 0.0012 0.0012 0.0012 0.0012 Potassium moth 0.001 0.001 0.001 0.001 0.001 Sodium selenite 0.0004 0.0004 0.0004 0.0004 0.0004 Citric acid AN AN AN AN AN KOH AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN AN 6-10 Examples 6-10 illustrate examples of nutritional emulsions of the present invention, the ingredients of which are set forth in the table below. Unless otherwise stated, all quantities are listed in kilograms per 1000 kilograms of product. Ingredient Example 6 Example 7 Example 8 Example 9 Example 10 Appropriate amount of water Appropriate amount of appropriate amount of sucrose 89.3 89.3 89.3 89.3 89.3 Maltodextrin 29.7 29.7 29.7 29.7 29.7 Casein sodium 25.9 25.9 25.9 25.9 25.9 Milk protein concentrate 19.1 19.1 19.1 19.1 19.1 CLA 14.2 13.5 14.9 12.8 15.6 Soy protein isolate 11.9 11.9 9.9 12.9 13.9 Potassium citrate 7.9 7.9 7.9 7.9 7.9 Soybean oil 6.4 5.4 6.4 6.4 6.4 HMB calcium 6.7 7.7 8.7 5.7 4.7 161134.doc -20· 201233341 Camellia oil 5.5 5.5 5.5 5.5 5.5 Corn oil 4.6 4.6 4.6 4.6 4.6 Whey protein concentrate 3.5 3.5 3.5 3.5 3.5 Magnesium hydrogen phosphate 3.1 3.1 3.1 3.1 3.1 Perfume 2.0 2.0 2.0 2.0 2.0 Microcrystalline cellulose 2.0 2.0 2.0 2.0 2.0 Soy lecithin 1.5 1.5 1.5 1.5 1.5 Hydrogen phosphate Disodium dihydrate 1.3 1.3 1.3 1.3 1.3 Dipotassium hydrogen phosphate 0.985 0.985 0.985 0.985 0.985 Potassium chloride 0.729 0.729 0.729 0.729 0.729 Choline chloride 0.480 0.480 0.480 0.480 0.480 Ascorbic acid 0.469 0.469 0.469 0.469 0.469 Calcium carbonate 0.451 0.451 0.451 0.451 0.451 Sugar Spice 0.450 0.450 0.450 0.450 0.450 Creamer 0 .450 0.450 0.450 0.450 0.450 UTM/TM Premix 0.367 0.367 0.367 0.367 0.367 45% Potassium Hydroxide 0.323 0.323 0.323 0.323 0.323 Carrageenan 0.200 0.200 0.200 0.200 0.200 Water Soluble Vitamin Premix 0.185 0.185 0.185 0.185 0.185 Vitamin DEK Premix 0.067 0.067 0.067 0.067 0.067 Sodium chloride 0.060 0.060 0.060 0.060 0.060 Lancture 0.050 0.050 0.050 0.050 0.050 Vitamin A palmitate 0.0082 0.0082 0.0082 0.0082 0.0082 Corn oil carrier q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q q 194 mg 194 mg 194 mg 194 mg 194 mg Example 11 In this example, the stability of the nutritional emulsion including CLA, HMB, and protein was analyzed and compared to a control sample emulsion without CLA. Formulations for both the control sample nutritional emulsion and the nutritional emulsion including CLA are set forth in the table below. Unless otherwise stated, all ingredients are listed in kilograms per 1000 kilograms of product. These emulsions are prepared using the usual methods described herein. Ingredients Control Appropriate amount of sucrose containing CLA 89.3 89.3 161134.doc •21 - 201233341 Maltodextrin 29.7 29.7 Road protein nano 25.9 25.9 Milk protein concentrate 19.1 19.1 CLA 0.0 14.2 Soy protein isolate 11.9 11.9 Potassium citrate 7.9 7.9 Soybean oil 6.4 6.4 HMB calcium 6.7 6.7 Canola oil 5.5 5.5 Corn oil 4.6 4.6 Whey protein concentrate 3.5 3.5 Magnesium hydrogen phosphate 3.1 3.1 Perfume 2.0 2.0 Microcrystalline cellulose 2.0 2.0 Soy lecithin 1.5 1.5 Disodium hydrogen phosphate dihydrate 1.3 1.3 Potassium hydrogenate 0.985 0.985 Potassium chloride 0.729 0.729 Gasification choline 0.480 0.480 Ascorbic acid 0.469 0.469 Calcium carbonate 0.451 0.451 Spice 0.450 0.450 Creamer 0.450 0.450 UTM/TM premix 0.367 0.367 45% hydroxide if 0.323 0.323 Carrageenan 0.200 0.200 Water Soluble Vitamin Premix 0.185 0.185 Vitamin DEK Premix 0.0675 0.067 Gasified Sodium 0.0601 0.060 Starch 0.0500 0.050 Vitamin A Palmitate 0.0082 0.0082 Corn Oil (Carrier) Appropriate amount of vitamin d3 399 mg 399 mg Moth 194.4 mg 194.4 mg will be a nutritional emulsion Mounted in 240-ml plastic container and a method commonly used to carry out sterilization autoclave sterilization. Visual inspection surprisingly showed that after 12 months of storage at ambient temperature, nutritional emulsions including CLA and HMB calcium showed less sediment than controls including HMB calcium but excluding CLA (see Figure 1; The control sample and the right side are emulsions containing CLA). In other words, the nutritional milk 161134.doc -22- 201233341 solution includes CLA surprisingly improving the physical stability of the nutritional product containing HMB calcium after 12 months due to the formation of precipitates at the bottom of the container and the precipitation of significantly less precipitation. Example 12 In this example, a nutritional emulsion comprising CLA, HMB and protein, and a control sample without CLA were analyzed for the taste quality. In particular, since CLA provides a bitter taste and imparts strong throat irritation after direct ingestion, it is difficult to incorporate this functional ingredient into the nutritional product without significantly impairing the taste of the product to a commercially undesirable level. The sample emulsion was analyzed by the §;j sensory panel for the intensity of various flavors: sweet, salty, sour, bitter, flavor intensity, taste intensity (base) Intensity) and hope. Specifically, after the emulsion was prepared, 5 members of the training group consumed 8 nutrient ounces of each nutrient emulsion. After each lotion, each group member used the following table. The analysis tool (pr〇filer) listed in the article gives a rating to the taste. The average of the results is then taken.
如下文結果表中所示,令人驚奇地發現,包括CLA之營 養乳液之味道品質與不包括任何CLA之對照試樣非常類 161134.doc •23· 201233341 似。值得注意地且令人驚奇地,試樣間之苦味無差異。該 等結果表明,含有CLA之營養乳液與不包括CLA之對照乳 液具有類似之味道特徵,且自味道觀點而言將為商業上可 接受的。另外,該等結果表明,可調配包括CLA及HMB鈣 二者與蛋白質之組合之具有可接受之味道品質的營養產 品。 試樣 味道 分析工具結果 對照試樣(僅含有HMB) 甜味 1 '/2 酸味 1 臟味 '/2 苦味 — 氣味強度 — 鹼味強度 1 '/2 盼味 — 包括CLA+HMB之營養乳液 甜味 1 '/2 酸味 1 贼味 '/2 苦味 — 氣味強度 — 鹼味強度 1 'Λ 盼味 1 【圖式簡單說明】 圖1顯示實例11中針對穩定性及沉澱實施評價之兩種試 樣液體營養調配物。 161134.doc -24-As shown in the results table below, it was surprisingly found that the taste quality of the nutritional emulsion including CLA was similar to that of the control sample excluding any CLA 161134.doc • 23· 201233341. Notably and surprisingly, there is no difference in bitterness between the samples. These results indicate that a nutritional emulsion containing CLA has similar taste characteristics to a control emulsion that does not include CLA and would be commercially acceptable from a taste point of view. In addition, the results indicate that a nutritional product having acceptable taste qualities, including both CLA and HMB calcium in combination with protein, can be formulated. Sample Taste Analysis Tool Results Control Sample (HMB only) Sweet 1 '/2 Sour 1 Dirty '/2 Bitterness - Odor Strength - Base Taste Strength 1 '/2 Hope - CLA+HMB Nutritional Emulsion Sweet Flavor 1 '/2 sour taste 1 thief taste '/2 bitterness - odor intensity - alkali taste intensity 1 'Λ 盼味1 [Simple diagram of the diagram] Figure 1 shows two samples for evaluation of stability and precipitation in Example 11. Liquid nutritional formula. 161134.doc -24-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42580910P | 2010-12-22 | 2010-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201233341A true TW201233341A (en) | 2012-08-16 |
Family
ID=47069886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100148124A TW201233341A (en) | 2010-12-22 | 2011-12-22 | Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW201233341A (en) |
-
2011
- 2011-12-22 TW TW100148124A patent/TW201233341A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20130337144A1 (en) | Nutritional products comprising calcium hmb and conjugated linoleic acid | |
TWI519242B (en) | Nutritional emulsions comprising calcium hmb and soluble protein | |
TWI580363B (en) | Nutritional emulsions comprising calcium hmb | |
JP5892947B2 (en) | Nutritional powder containing spray-dried HMB | |
JP2017225453A (en) | Powdered nutritional formulations including spray-dried plant protein | |
NO20110273A1 (en) | Nutritionally complete breast milk substitute | |
JP2013528060A (en) | Substantially clear nutrient liquid containing calcium HMB and soluble protein | |
JP2016501037A5 (en) | ||
JP2016501037A (en) | Low viscosity, high caloric density oral nutritional compositions and related methods | |
US20160158287A1 (en) | New prophylactic use for prevention of infections | |
WO2013148688A1 (en) | Pea protein containing nutritional compositions | |
JP2016512686A (en) | Nutritional composition comprising calcium β-hydroxy-β-methylbutyrate, casein phosphopeptide and protein | |
TW201735801A (en) | Nutritional products comprising beta-hydroxy-beta-methylbutyrate | |
US20160021921A1 (en) | Preterm infant nutritional compositions containing beta-hydroxy-beta-methylbutyric acid | |
TW201212829A (en) | Methods for enhancing cognition and/or memory using maltodextrins | |
US9693577B2 (en) | Method of preparing a nutritional powder comprising spray dried HMB | |
TW201233341A (en) | Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid | |
WO2022163760A1 (en) | Gel-like nutritional composition | |
EP2986162A1 (en) | Low calorie infant formula containing | |
JP2000119180A (en) | Enteral nutrient | |
JP2005154401A (en) | Deodorizing composition for feces |